LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Strona główna・Stock List・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Closed

Sector Healthcare

194.18 0.11

Buy Sell

Overview

Share price change

24h

Current

Min

191.41

Max

196.76

Key metrics
By Trading Economics
Income	27M 94M
Sales	20M 1B
P/E Sector Avg	24.27 112.16
EPS	2.8
Profit margin	9.134
Employees	20,000
EBITDA	19M 239M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+4.84 upside

Market Stats
By TradingEconomics
Market Cap	98M 10B
Previous open	194.07
Previous close	194.18

News Sentiment

By Acuity

50%

172 / 366 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

189.33 / 198.565 Support & Resistance

Charles River Laboratories International Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 sie 2024, 10:30 UTC

Peer Comparison

Price change

Charles River Laboratories International Inc Forecast

Price Target

By TipRanks

4.84% upside

12 Months Forecast

Average 203.25 USD 4.84%

High 250 USD

Low 151 USD

Based on 12 Wall Street analysts offering 12 month price targets forCharles River Laboratories International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Charles River Laboratories International Inc - Dist in the past 3 months.

Technical Score

By Trading Central

189.33 / 198.565Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

172 / 366 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.